Health Archive » November, 2021

Health - November, 2021

372 articles

• NY Says Amazon Should Be Forced To Address COVID Safety
• High Court's Right Flank Floats Chevron Deference Overhaul
• Jury Says BGI Owes Illumina $8M For Infringing DNA Patents
• 'God's Tigress': Feds Query Holmes On Balwani 'Love' Texts
• Biden Vax Mandate Preliminarily Blocked By La. Federal Judge
• FDA Panel Backs Merck COVID Pill For High-Risk Adults
• Name-Changing Ransomware Crew Hits Schools, Hospitals
• Kavanaugh Seen As Key Vote In Roe Showdown
• NJ Justices Probe 'Muzzling' Bankruptcy Clause In Settlement
• Justices Open To Emotional Distress Damages In Bias Row
• Chicago Woman Gets 56 Mos. In $6.3M Medicare Fraud Case
• Behind The Scenes With Opioid Attys At Landmark Jury Trial
• CBP Issues New Guidance For Infant, Pregnant Detainee Care
• DOJ's 1st Wage-Fixing Case Survives Dismissal Bid
• Parents, Fla. Agree New Law Moots School Masks Rule Suit
• Meet The Attys Battling Over The Future Of Abortion Rights
• 11th Circ. Sends Drug Effect Questions To Ala. High Court
• Universal Health Slams 'Audacious' Fee Bid In Investor Suit
• Nevada Pot Shop Faces $487K Fine, Ban Over Stolen Plants
• Med Device Case Highlights Physician IP Deal Best Practices
• Wiley Adds Trillium Health GC To Health Care Practice
• Judge Blocks Biden's Contractor Vax Mandate In 3 States
• Judge Says Attys For Biotech Whistleblower Should Get $6M
• Ex-OSI Controller Gets 3 Years For Insider Trading Conviction
• Without Leadership Buy-In, Law Firm DEI Efforts Stand To Fail
• 'Indecipherable' Medicare Law Leaves High Court Flummoxed
• Holmes Says Ex-Theranos Exec Controlled And Abused Her
• Court Hears NJ Judge Must Face Psychiatric Exam In Suit
• J&J's Bankruptcy Move To NJ Cracks Door For Dismissal Bid
• Catalent Can't Duck IP Suit Over Epilepsy Drug Vimpat
• Kansas Hospital Sues HHS Over Drug Reimbursements
• WTO Delays Talks Over IP Waiver Amid New Variant Concerns
• Mallinckrodt Gets Ch. 11 Stay Of Acthar Suits Extended
• Confronting Origination Credit: Self-Advocacy Tips For Attys
• Polsinelli Snags Health Care Atty From Nossaman
• Hagens Berman Stalling Thalidomide Suits Probe, Clients Say
• CORRECTED: Ex-NFL Players Reveal Alleged Drug System
• Gulf Coast Defuses Ch. 11 Loan, Site Management Disputes
• Surgical Robot Co. Must Face Instruments Antitrust Claims
• 5th Circ. Freezes Texas Judge's School Mask Mandate Ruling
• Real Estate Rumors: Brookwood, SRM Development, Tricera
• Reed Smith Steers Fintech-Oriented SPAC's $250M IPO Filing
• 7th Circ. Tosses Iraq War Vet's VA Suit As Duplication
• Convicted Ex-Insys Execs Must Pay $48.3M To Victims
• Gordon & Rees Snaps Up Veteran Litigator In Nevada
• Novartis Wants Atty DQ'd From MS Drug Patent Row In Del.
• A Real-World Guide To Staying Discovery In Federal Court
• Teva Attorneys Leave Goodwin Procter For Greenberg Traurig
• Pharma Biz Hits Back At Contractors In Contamination Row
• Holmes Admits Adding Pfizer Logo To Reports For Walgreens
• Despite Jury Win, Opioid Attys Predict 'A Long Way To Go'
• Pfizer Says Employee Stole Confidential Docs On COVID Vax
• Ga. Dental Board Members Try Again To Toss SmileDirect Suit
• Pet Care Co. Hit With ERISA Suit Over Retirement Plan Fees
• Fed. Circ. Says Why It Revived IP Case Against Fujifilm
• Gulf Coast Pressed On Lack Of Sale Push Before Ch. 11 Filing
• 3rd Circ. Says Couples Can't Challenge Pa. COVID Measures
• Michigan Hospital Group Reaches Deal To Wrap Up ERISA Suit
• Texas Panel Lets Infant Death Suit Proceed Against Docs
• Surgery Partners Gets $45M In Settlement With HIG, Bain
• Ga. Judge Orders Cardi B Medical Records In Libel Case
• Judge Scolds Atty For 'Hostile' Court Messages, Limits Access
• Rehab Joint Venture Is Kickback Minefield, Watchdog Says
• Williams Mullen Nabs Ex-NC Health Department Atty In Raleigh
• Lawmakers Urge Biden To Stand Firm On COVID IP Waiver
• Judge Discharges Hospital's Suit Over Botched Settlement
• Texas Panel Sides With Dallas In Mask Mandate Row
• Rutgers, College Of NJ Aim To Erase Vaccine Mandate Suits
• Medicare Fraud Exoneree Can't Seek Damages, 5th Circ. Says
• India-Focused SPAC Leads 2 Public Debuts Totaling $236M
• United Workers Can't Halt Vax Mandate Amid 5th Circ. Appeal
• Pharmacy Giants Fueled Opioid Crisis, Ohio Jury Finds
• 14 States Urge High Court To Back Fla. In Medicaid Dispute
• Illumina's Bid For $25M Over DNA Tech Patents Goes To Jury
• Sanofi Unit To Pay $180M In Disease Treatment Patent Fight
• Holmes Testifies She Thought Theranos Could Do 'Any Test'
• NY Hospital Gets Win Affirmed In Suit Over Rare Disorder
• Mass. Vets Home Operators Avoid Charges Over Virus Deaths
• Wash. Businesses Ask 9th Circ. To Revive Virus Suits
• Judge Rejects Probe Of Asbestos Votes In Mallinckrodt Ch. 11
• Medical Service Co. Hit With $27M Verdict Over Amputated Leg
• DOJ-Walmart Opioid Battle Halted As High Court Reviews CSA
• J&J Talc Claimants Vow To End Unit's 'Bad Faith' Ch. 11 Case
• Insurer Says It's Off The Hook For $32M Kraft Heinz Verdict
• Pesticide Use Targeted In New Senate Farmworker Safety Bill
• Hospital Group Strikes $2M Deal To End ERISA Fee Suit
• PruittHealth Will Pay $4.2M To End In-Home Care FCA Suit
• No Redo For Death Suit Over Knee Replacement Surgery
• Ga. Women Lob Class Claims At Health Co. Over Mud Product
• Ex-Coaches Sue Washington Nationals Over Vaccine Mandate
• Fla. Can't Block Federal Health Care Staff Vaccine Mandate
• Choosing The Right IP Protections For Telehealth Innovations
• Medical Cannabis Co. Akanda Files Confidential IPO Docs
• Davis Polk Report Finds Further Cuomo Misconduct
• Calif. Employment Law Firm DLaw Opens SF Office
• Doc Says Exposing Hospital's 'Patient Dumping' Led To Firing
• Pitt Beats Croatian Ex-Instructor's Bias Suit
• Convicted Illumina Insider Trader Loses $4.5M Forfeiture Fight
• Quest Diagnostics Fertility Biz Sued Over Data Breach
• Supreme Court Won't Review Kodak Injury Claims From Ch. 11
• 4 Firms Lead $17B PE Buyout Of Athenahealth
• Philips Can't Add New Fitbit Products To Patent Suit
• Illumina Defends Validity Of DNA Sequencing Patents At Trial
• 3rd Circ. Sinks Heart Monitor Co.'s BCBS Antitrust Case
• Celebrity Trainer Tells Chancery Franchise Owes Legal Fees
• Budget Bill May Boost Unauthorized Immigrants' Health Care
• Acthar Claimants Seek Mallinckrodt Chapter 11 Vote Probe
• Suzanne Somers Drops QVC Nutritional-Supplement Suit
• Texas Appeals Court OKs Temporary Block Of Delta-8 Ban
• Texas Judge Stands By Ruling In United Airlines Vaccine Fight
• Holmes Tells Jurors Some Investors Didn't Want Theranos Info
• FDA, CDC Panel Clear COVID Boosters For All Adults
• To Vax Or Not To Vax Is Not A Constitutional Question
• Mitigating Inflation's Impact On Commercial Contracts
• Fla. Pharma Co. Brings Trade Secrets Suit Over Cancer Work
• Mass. AG Targets 2 Home Health Cos. In Fraud Crackdown
• Israeli Banker In Insider Trading Ring Gets 2.5 Years
• Health Hires: Baker Donelson, Proskauer
• How DOJ May Beat The White Collar Fraud Clock Post-COVID
• Horse-Doping Vet Asks For No Prison With Life In 'Shambles'
• Sorrento Escapes COVID-19 Investor Class Action
• Insurance Tips For Mitigating DOJ Cyber Initiative Risks
• Texas Justices Side With ExxonMobil On Explosion Discovery
• Insurers Have Edge In Georgia COVID-19 Coverage Fights
• House Sends Biden's $1.75T Budget Plan To Senate
• Fortune Writer Claims Holmes Duped Him As DOJ Wraps Case
• 11th Circ. Won't Seal Emails In Organ Donation Fight
• Purdue Cleared To Pay Gov't Groups Over $12M In Ch. 11 Fees
• Creditors, Agencies Say No To Gulf Coast Nursing Home Deal
• New Laws, Suit Step Up Fla. Fight Against Vaccine Mandates
• Ill. Justices Nix New Trial In Med Mal Wrongful Death Suit
• CMS Vaccine Rules Could Create FCA Risks For Cos.
• NJ Panel Won't Revive Suit Over Fall From Operating Table
• Verrill Adds Lead Prosecutor On Insys Case To Boston Office
• Bass Berry Adds 7 Attys To Health Care Group In DC, Tenn.
• NJ Firm Accused Of Overcharging Benicar MDL Clients
• Real Estate Rumors: DR Horton, AMAC, Wells Fargo
• FCC Requires Carriers To Allow Texting To Suicide Hotline
• Mallinckrodt Ch. 11 Plan Hearing Won't Restart Monday
• 'Laws Of Chemistry' Trump PTAB, Illumina Rival Tells Jury
• Theranos Patient Got Incorrect HIV Test Result, Jury Told
• Biden Plans To Expand COVID-19 Vaccine Supply By 2022
• Mallinckrodt Denies Manipulating Acthar Market
• Drugmaker Says 11th Circ. Ruling Based On 'Straw Man'
• COVID 'Devastating' For Opioid Epidemic, Wash. Judge Told
• Fed. Circ. Nixes Nurse's Bid To Be Added To Neck Restraint IP
• Reps. Move Telecom Bills On Maternal Health, Spectrum Use
• Ohio Counties Deride Pharmacies' Opioid Mistrial Bid
• Consumer Counsel Gets $115M From EpiPen Settlement
• $600K For Atty Fees Awarded In Pot Co. Investor Settlement
• How DOD's Climate Focus Will Affect Gov't Procurement
• Pa. Hospitals Can't Shake Workers' Suit Over No-Poach Deal
• Heed These Rules, Or Risk Your Argument On Appeal
• Texas Hospital Workers Fight Vaccine Mandate At 5th Circ.
• Teva Says Dr. Reddy's Broke Deal Over Birth Control Device
• Skadden's Allison Brown On J&J's Talc Trial Win In Mo.
• Employer Vaccine Bargaining Duties After NLRB Memo
• Teva, Cooper Cos. Must Face All Claims In Paragard IUD MDL
• Unvaxxed Athletes Settle Religious Claims Against College
• Investors Gave Theranos $96M Despite Due Diligence Gaps
• Michigan Town Ducks Weed Growers' Pot Raid Suit
• Ill. Man Admits Aiding Rabbi's Health Investment Fraud
• Walmart Seeks Early Win Over Trucker's Bias Suit
• Pharmacies Urge Mistrial In Opioid Case As Jury Deliberates
• Health Insurer Gets Pandemic Firing Suit Trimmed
• Purdue Claimants Say Ch. 11 Appeals Threaten Recoveries
• Pfizer Wants FDA Emergency Approval For COVID Treatment
• Pfizer Must Face Trimmed Robitussin Labeling Suit
• Texas Home Care Co. Must Face Sex Assault Claims
• Ill. Neurologist Must Face Patient's Brain Infection Suit
• Whistleblowers Defend FCA Suit Against HIG Capital
• FTC Tells High Court Impax Ruling Needs No Review
• What To Include In Orders Governing Remote Arbitration
• Mallinckrodt Says Insurers' Acthar Claims Off By $317M
• Foley Hoag Pulls In Ex-SDNY Fraud Chief From Baker Botts
• Staffing Firm Asks High Court To Leave Travel Pay Out Of OT
• 8th Circ. Won't Touch $3.2M Atty Fees In Foster Kids' Suit
• 6th Circ. ERISA Ruling Highlights Dubious Court Practices
• Brownstein Hyatt Adds Consultant To Gov't Relations Team
• Theranos Investor FOMO Is Due Diligence Lesson, Attys Say
• Wash. AG Steals Defense Thunder As $95B Opioid Trial Starts
• Lax Pharmacies Fed Opioid Crisis, Jury Told As Trial Ends
• Theranos Investor Emailed Prosecutors During Trial, Jury Told
• Federal Cannabis Reform Turns New Leaf With GOP Bill
• FDA Scraps Trump-Era Leeway For Lab Test Authorizations
• Ill. Jury Awards $15M In Med Mal Suit Alleging Brain Damage
• Mallinckrodt Exec Says Acthar Price Hikes Were Necessary
• Texas Oil Driller Escapes Liability In Rig Worker's Stroke Suit
• 9th Circ. Sides With Anthem In Health Coverage Battle
• Embracing ESG: CBRE GC Talks Effective Compliance Emails
• Examining EU's Drift Toward US-Style Employer Pact Scrutiny
• Imerys Judge Won't OK Mediation Without Clear Rules
• NJ Hospital Wins Another Look At Late Med Mal Notice
• Philips Claims Order A Hurdle To Fixing Sleep Apnea Devices
• Supreme Court Declines To Enter Flanax TM Fight
• High Court Won't Upset $114M FCA Medicare Fraud Judgment
• Ind. Health Providers Must Face Suit Over Murder By Patient
• 5th Circ. Affirms Block Of Employer Vax-Or-Test Rule
• 5 Key Details As Drama Surrounds $95B Opioid Trial In Wash.
• 3rd Circ. Risks Twisting COVID Immunity Law Into Pretzel
• Insurers Say Mallinckrodt Sales Strategy Cost Them $320M
• Convicted Illumina Insider Trader Fights $4.5M Forfeiture
• 7th Circ. Again Asked To Revive Becton Buyers' Antitrust Suit
• Philly Jury Awards $9.7M In Med Mal Trial Over Brain Injury
• 9th Circ. Jurisdiction Ruling Guides On Class Action Strategy
• United Workers Say Judge Overlooked Harms In Vaccine Fight
• The Hazards Of Female Lawyers Being 'Office Moms'
• Buchalter Adds Three Attys To San Diego Office
• Hall Booth Nabs In-House Counsel For Health Care Team
• Horizon Taps Ex-NJ Human Services Commissioner As GC
• J&J's Win In Opioid Health Insurance Class Action Is Affirmed
• 7th Circ. Nixes $8M Verdict In Ex-Prisoner's Med Mal Suit
• CVS Drops High Court Disability Bias Battle With HIV Patients
• Biden Taps Ex-FDA Boss Califf To Lead Agency Again
• Cravath, Baker McKenzie-Led J&J Plans Consumer Biz Spinoff
• $626M Flint Water Deal OK'd, $202M Atty Fee Addressed Later
• Theranos Exec Threatened Investor With Litigation, Jury Told
• United Therapeutics Beats HHS' Discount-Dodging Claims
• 11th Circ. Told PREP Act Preempts COVID Death Suit
• FTC Judge Says Amici Offer Nothing New In Illumina Case
• Overdose Reversal Drug Maker Settles FCA Suit For $12.7M
• Fed. Circ. Orders Albright To Transfer Another Patent Case
• NY Court Reinstates Claims In Nursing Home Death Suit
• FTC Orders 2 Generics Divested In $210M Pharma Deal
• X-Ray Co. Can't Escape Its Part Of $2.5M Collision Verdict
• Opioid Litigation's Pillar Theory Is Suddenly Showing Cracks
• IHS Announces $46.4M For Tribal Behavioral Health Programs
• Discovery Immunity For Draft Expert Reports Lacks Clarity
• What CMS Vaccine Rule May Mean For Health Care Employers
• Humana FLSA Case Shows Risks Of Nurse Misclassification
• Reed Smith Hires Prosecutor In Major FCPA, Crypto Cases
• Texas Ban On School Mask Mandates Struck Down By Judge
• Seyfarth Atty Jumps To Cozen O'Connor's Health Care Team
• J&J Talc Liability Unit's Ch. 11 Transferred To NJ
• 5 Tips For Navigating The Vax-Or-Test Mandate
• Paul Weiss Helps General Atlantic Snag $7.8B For Latest Fund
• Ex-Theranos Lab Chief Doubted Holmes' 'Implausible' Takes
• COVID Apps Can't Force Action Against Apple, FTC Says
• Navy SEALs Say Vax Mandate Denies Their Religious Rights
• Freezer Maker Can't Get Redo Of $15M Verdict Over Embryos
• Navajo Leaders Slam Tribal Developers' Medicaid Oversight
• Purdue Agrees Not To Finalize Ch. 11 Plan Until Appeals Done
• Pa. Businesses Ask 3rd Circ. To Overturn Virus Policy Rulings
• Ga. Doctors Pay $28M To Settle Anesthesia Kickback Claims
• Wis. Clinic Must Face Suit Over 12-Year-Old's Crushed Toe
• A Phased Approach To In-House Legal Tech Adoption
• Lawyers Seek $1.9M In Fees After P&G DACA Settlement
• Brach Eichler Adds Veteran NJ Health Care Member
• Paul Weiss, Gibson Dunn Steer GE's Split Into 3 Cos.
• Okla. High Court Overturns J&J's $465M Opioid Defeat
• 4 Economic Takeaways From 6th Circ. ProMedica Decision
• Feds Ask 5th Circ. To Unblock Employer Vax-Or-Test Reg
• United Workers Can't Ground Airline's Vaccine Mandate
• Fertility Lab Sued Over Switched-Embryo 'Nightmare'
• Medical Device Co. To Pay $16M Over Kickback Allegations
• Sanofi, Whistleblower Settle 19-Year Cancer Drug FCA Battle
• 8th Circ. Won't Block Feds' Kidney Transplant Reform
• Insurers Claim Mallinckrodt Inflated Acthar Price By $300M
• Mich. Appeals Court Upholds Suspension For Pot Doctor
• State AGs Join FTC Opposing NJ Hospital Merger At 3rd Circ.
• Eye Clinic Can't Avoid Whistleblowers' Kickback Claims
• Mercy Health Agrees To $4M Deal In Retirement Fund Fight
• No Fast Appeal After Actor Health Plan Fails To Nix ERISA Suit
• Mine Workers Want Arbitration Win On Health Care Confirmed
• DOJ Claims Texas Pharmacy Co. Inflated Ingredient Pricing
• 'Flanax' TM Case Could Bring High Court Clarity On 2 Issues
• Sanctions Sought Over PI Hired By Doctor In Med Mal Case
• Fla. School Boards Appeal After Losing Suit Over Mask Limits
• Court Ends Immigrants' Suit Over Trump Insurance Order
• Med. Billing Co.'s Ransomware Attack Coverage Suit Revived
• Fla. Man Admits To $1M Genetic Testing Kickback Scheme
• Confronting Origination Credit: How Firms Can Redo Policies
• Shkreli's Old Co. Fair Game For Antitrust Trial, Judge Says
• 5th Circ. Blocks DOL Vax-Or-Test Reg, Citing 'Grave' Concerns
• J&J's Ch. 11 Talc Stay Deferred Until Case Venue Is Decided
• 4 BigLaw Players In Elizabeth Holmes' Criminal Fraud Trial
• NJ Judge Pauses Sanctions For Discount-Dodging Drug Cos.
• 2 Sun Pharma US Units To Pay $85M In Generic Drugs MDL
• Bristol-Myers Inks $10M Deal To End Drug Antitrust Claims
• 1st Circ. Won't Delete 10-Year Sentence For 'Hacktivist'
• 3rd Circ. Preview: Gun Ad Probe, 'Joke' Tweet Mark November
• Fed. Circ. Won't Let Celgene Challenge Mylan's Generic In NJ
• ITC To Probe Imports Of Cannabis Oil-Vaping Products
• Northern Arapaho Asks 10th Circ. To Reverse $1.5M Gov't Win
• Biden Admin. Urges Ariz. Judge To Keep Vax Mandate Intact
• States Seek 11th Circ. Review Of Employer Vaccine Mandate
• Mallinckrodt Cleared On $94M Ch. 11 Bond Penalty
• FTC Got NJ Hospital Market Right, Academics Tell 3rd Circ.
• J&J Unit's Ch. 11 Committee Approved Over Venue Concerns
• High Court To Review DaVita's Dialysis Bias Fight
• Law360's Tort Report: Pa. Justices Weigh Key Med Mal Issue
• Dental Co. Sues Competitor Over Claims Of Effectiveness
• Ill. Plasma Center Reaches $9.9M Deal To End BIPA Suit
• How To Comply With ABA's New Language Access Guidance
• US Supreme Court To Hear Ala. 'Pill Mill' Conviction Case
• Harvard Group Faults Feds' $20B Allocation Of Tribal Funds
• Pain Doctor DQ'd As Expert In Post-Op Nerve Block Suit
• Texas Challenges 'Flatly Unconstitutional' Vaccine Rule
• UnitedHealth Unit Stingy On Residential Treatment, Suit Says
• Etsy Ducks Face Mask Sales Tax Suit In Pennsylvania
• Texas Clinic Beats Trooper's Suit Over Hemorrhoids Rumor
• UK Litigation Roundup: Here's What You Missed In London
• Reynolds Responsible For Lung Cancer Death, Fla. Jury Hears
• Holmes Cited Walgreens Deal In Rushing Investors, Jury Told
• Cherokee Nation Bashes Pharmacies' Prescription Data Bid
• Apple Seeks Toss Of COVID App Programmer's Antitrust Suit
• 6 More States Sue Biden Over Gov't Contractor Vax Mandate
• 5 Takeaways From Drugmakers' Win In Calif. Opioid Trial
• Gov. Says Fla. Will Sue Over Private-Sector Vaccine Mandate
• La. Court Affirms Toss Of Med Mal Suit Over Hip Fracture
• Mallinckrodt Can Duck Acthar Royalties In Chapter 11
• FTC Questions Academics' Interest In Backing Illumina
• Shkreli Won't Take The Stand At FTC Antitrust Trial
• Kaiser Says Workers Rely On 'Bizarre' Theories In Vax Row
• Md. Attys Escape Claims Of Botched Med Mal Settlement
• Gulf Coast Asks To Transfer Nursing Home Control In Ch. 11
• Faulty Dirt Bike Caused Maryland Tween's Amputated Finger
• ICE Faces Medical Staffing Hurdles At Detention Sites, IG Says
• Boston Hospital Workers Lose 2nd Bid To Block Vax Mandate
• Biden Admin. Unveils COVID Rule For Private-Sector Workers
• Novartis Sells $20.7B Stake In Fellow Swiss Pharma Co. Roche
• Boies Said Theranos Tech Was Sound, Investors' Atty Testifies
• VA Nurse Practitioners Ink $160M Deal Resolving OT Claims
• J&J Unit Says Ch. 11 Stay Extension Needed To Handle Claims
• Walgreens Must Face Trimmed Investor Stock-Drop Claims
• Iowa Hospital Must Face Patient's Slip-And-Fall Claims
• Subcommittee Passes Broadband Bills But Leaves Backlog
• Novartis Fights Enhanced Damages Bid After $178M Jury Loss
• Hartford Escapes Physiotherapy Co.'s Virus Coverage Suit
• 3 Practice Tips For Patenting Medical Devices In A Digital Age
• How To Minimize FCA Cyber Fraud Enforcement Risk
• Trader Who Profited From Illegal Illumina Tips Gets 3 Years
• Invisalign Maker's $16M Investor Deal Gets Initial Nod
• Ark. Lab Owner Charged With $100M COVID-19 Fraud Scheme
• Best Practices For Hiring And Integrating Freelance Lawyers
• Prof's Legal Tab Not Harvard's Problem, Mass. Top Court Hints
• Case Law, EEOC Guidance Bolster Employer Vax Mandates
• Ex-Cravath Atty Introduced Rich Clients To Holmes, Jury Told
• CDC Recommends Pfizer Vaccine For Children Aged 5 To 11
• Walmart Tells 5th Circ. Its Pharmacists Are Stuck Over Opioids
• Antitrust Group Says Mallinckrodt Plan Lacks Sufficient Votes
• Teligent's Creditors Decry 'Skewed' Bankruptcy Financing
• Indicted Doc In Kickback Case Seeks CMS Billing Privileges
• How Hueston Hennigan Notched A Landmark Opioid Trial Win
• United Airlines Workers Want Class Cert. In Vax Mandate Suit
• Feds Nail Podiatrist For Alleged $11M Foot Bath Fraud Scheme
• Pa. Hospital Urges Court To Nix Simultaneous Surgery Suit
• Contractor Flipped Workout Machines On Amazon, Suit Says
• Calif. Court Affirms Hospital Fall Suit Filed Too Late
• Foley Taps New Managing Partners In NY, Boston
• Illumina Says Convicted Insider Trader Broke Investors' Trust
• NorthShore Can't Dock Pay In Vax Mandate Row
• Senate Panel Mulls Role Of Big Tech In Counterfeit Problem
• Insurance Commissioner's Agenda: NY On Industry Diversity
• Arent Fox Settles Unpaid Legal Fees Dispute With Pharma Co.
• Jury Awards Boston Scientific $20M In Nevro Patent Trial
• Rite Aid Settles With DOJ To Make Accessible Vaccine Sign-Up
• Drugmakers Not Liable For Calif. Opioid Crisis, Judge Finds
• KPC, Alerus Must Face Most Claims In $227M Stock Buy Suit
• Judge Reluctantly Rejects Virus Coverage For NJ Orthodontist
• Hospital System Defends Antitrust Exemption To High Court
• DOJ Can't Get Notice Of Cancer Exec's Expert Witnesses
• Embracing ESG: Cognizant Counsel, CSO Talk Collaboration
• Mallinckrodt Ch. 11 Hearing Starts With Valuation Questions
• FTC Defends Blocking NJ Hospital Merger At 3rd Circ.
• Judge Nixes Trade Group's Suit Over NJ Public Bidding Law
• Faegre Drinker Adds Ex-Advarra Pharma Regulatory Adviser
• Oshkosh Must Comply With UAW Local's Arbitration Award
• Justices Tackle 'Procedural Morass' In Texas Abortion Cases
• As Social Impact Becomes The Test, Firms Asked To Step Up
• The 2021 Law360 Pulse Social Impact Leaders
• Social Impact Leaders: A Look At Our New Law Firm Ranking